Zivo Filed Prospectus For 2,996,260 Shares Of Common Stock Underlying Series A Common Warrants And Series B Common Warrants By Selling Stockholder
Portfolio Pulse from Charles Gross
Zivo Bioscience has filed a prospectus for 2,996,260 shares of common stock underlying Series A and Series B common warrants by a selling stockholder. The filing was made with the SEC.
July 28, 2023 | 10:08 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Zivo Bioscience has filed a prospectus for nearly 3 million shares of common stock underlying Series A and B common warrants. This could potentially dilute the value of existing shares.
The filing of a prospectus for nearly 3 million shares of common stock underlying Series A and B common warrants by Zivo Bioscience could potentially dilute the value of existing shares, leading to a negative impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100